MiRNA-429 suppresses the growth of gastric cancer cells in vitro

Journal of Biomedical Research

Volumn 26, Issue 5, 2012, Pages 389-393

  Liu, Di ^a   Xia, Peng ^a   Diao, Dongmei ^a   Cheng, Yao ^a   Zhang, Hao ^a   Yuan, Dawei ^a   Huang, Chen ^a   Dang, Chengxue ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Gastric cancer; MicroRNA

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 429; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER;

EID: 84870881148     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.26.20120029     Document Type: Article

References (26)

1. Esteller M Non-coding RNAs in human disease. Nat Rev Genet 2011, 12:861-874.
2. Bhatt K, Mi QS, Dong Z microRNAs in kidneys: bio-genesis, regulation, and pathophysiological roles. Am J Physiol Renal Physio 2011, 300:F602-F610.
3. Van Rooij E The art of microRNA research. CircRes 2011, 108:219-234.
4. Lima RT, Busacca S, Almeida GM, et al. microRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 2011, 47:163-174.
5. Davis-Dusenbery BN, Hata A microRNA in Cancer: the involvement of aberrant microRNA biogenesis regulatory pathways. Genes Cancer 2010, 1:1100-1114.
6. Farazi TA, Spitzer JI, Morozov P, Tuschi T miRNAs in human cancer. J Pathol 2011, 223:102-115.
7. Fabian MR, Sonenberg N, Filipowicz W Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010, 79:351-379.
8. Lin SL, Chang DC, Ying SY, Leu D, Wu DT micro-RNA miR-302 inhibits the tumorigenecity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res 2010, 70:9473-9482.
9. Pickering MT, Stadler BM, Kowalik TF miR-17 and miR-20a temper an E2F1-induced G1 checkpoint to regulate cell cycle progression. Oncogene 2009, 28:140-145.
10. Pang RT, Leung CO, Ye TM, Liu M, Chiu PC, Lam KK microRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 2010, 31:1037-1044.
11. Mateescu B, Batista L, Cardon M, Gruosso T, de Feraudy Y, Mariani O miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response. Nat Med 2011, 17:1627-1635.
12. Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med 2011, 18:74-82.
13. Eades G, Yang M, Yao Y miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J Biol Chem 2011, 286:40725-40733.
14. Borralho PM, Simões AE, Gomes SE miR-143 over-expression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One 2011, 6:e23787.
15. Saini S, Majid S, Yamamura S, Tabatabai L, Suh SO, Shahryari V Regulatory role of miR-203 in prostate cancer progression and metastasis. Clin Cancer Res 2011, 17:5287-5298.
16. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.
17. Hu X, Macdonald DM, Huettner PC, Feng Z, EI Naga IM, Schwarz JK A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer. Gynecol Oncol 2009, 114:457-464.
18. Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance. PLoS One 2011, 6:e29043.
19. Fabian MR, Sundermeier TR, Sonenberg N Under-standing how miRNAs post-transcriptionally regulate gene expression. Prog Mol Subcell Biol 2010, 50:1-20.
20. Kota J, Chivukula RR, O'Ronnell KA, Wentzel EA, Montgomery CL, Hwang HW Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
21. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH Functional links between clustered microRNA: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009, 37:1672-1681.
22. Sempere LF Integrating contextual miRNA and protein signatures for diagnostic and treatment decisions in cancer. Expert Rev Mol Diagn 2011, 11:813-827.
23. Tryndyak VP, Beland FA, Pogribny IP E-cadherin transcriptional down-regulation by epigenetic and microR-NA-200 family alterations is related tomesenchymal and drug-resistant phenotypes in human breast cancer cells. Int J Cancer 2010, 126:2575-2583.
24. Yang H, Kong W, He L, Zhao JJ, O'Donnel JD, Wang J micorRNA expression profiling in human ovarian cancer. miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008, 68:425-433.
25. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008, 141:672-675.
26. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY miR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.